RHS Financial LLC Reduces Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

RHS Financial LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.8% during the 4th quarter, Holdings Channel.com reports. The fund owned 1,141 shares of the medical equipment provider’s stock after selling 58 shares during the period. RHS Financial LLC’s holdings in Intuitive Surgical were worth $596,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of ISRG. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the 4th quarter valued at about $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical in the 3rd quarter valued at approximately $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 28,843 shares of company stock valued at $15,357,560 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $571.88 on Friday. The stock has a 50-day simple moving average of $549.92 and a 200-day simple moving average of $508.00. The stock has a market capitalization of $203.69 billion, a P/E ratio of 89.22, a PEG ratio of 5.52 and a beta of 1.39. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Analyst Upgrades and Downgrades

Several research firms have weighed in on ISRG. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price for the company. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research note on Friday, October 18th. Leerink Partners boosted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Finally, Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.